Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma therapy vs standard of care in severe COVID-19 (case-control study)
TCTR20220101003Completed
- Sponsor
- Center of Learning and Research in Celebration of HRH Princess Chulabhorn 60th Birthday Anniversary
- Start
- Jun 2021
- Countries
- 1
01
Overview
Open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Center of Learning and Research in Celebration of HRH Princess Chulabhorn 60th Birthday Anniversary. Started Jun 2021; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on TCTR20220101003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220101003.